arrow
G

Gun Min Kim

yonsei university health system
H指数:23
被引数:2,233

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer” [604 (2024) 217219 1–12]

勘误:“联合抑制CDK4/6和AKT对三阴性乳腺癌的腔内雄激素受体(LAR)亚型具有高度有效性” [604 (2024) 217219 1–12]

2025-07-050
PRE
Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (−) metastatic breast cancer patients in Korea (KCSG BR21-15)

韩国全国范围内帕博西利(palbociclib)在HR(+)、HER2(−)转移性乳腺癌患者中的真实世界实践模式与临床数据(KCSG BR21-15)

2025-05-120
OA
Age- and ethnic-driven molecular and clinical disparity of East Asian breast cancers
2024-09-270
OAAI
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer
2024-08-220
OA
Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial (jun, 10.1038/s41591-024-03060-0, 2024)
2024-06-240
OAAI
Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial
2024-06-012
OAAI
Comparison of clinical efficacy between letrozole plus ribociclib vs. Fulvestrant plus letrozole plus ribociclib in Hormone receptor positive, HER2 negative metastatic breast cancer - a randomized, phase 2 study (KCSG BR22-20)
2024-05-020
PRE
Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA

肿瘤基因组和表观基因组的整合建模,以通过游离DNA增强癌症诊断

2023-04-109
OAAI